Effect of Treating Chronic Hepatitis C Infection with Direct-Acting Antivirals on The Risk of Recurrence Hepatocellular Carcinoma

Recurrence of Hepatocellular Carcinoma in Hepatitis (C) Virus Related Cirrhosis Treated with Direct Acting Antiviral Therapy

Hepatocellular Carcinoma Recurrence Post Direct-Acting Antiviral and Its Relation to Time of Treating Chronic HCV Infection

RECURRENCE RATE OF HEPATOCELLULAR CARCINOMA AFTER TREATMENT OF CHRONIC HEPATITIS C PATIENTS WITH DIRECT ACTING ANTIVIRALS: RANDOMIZED CONTROLLED PHASE 3 TRIAL. PRELIMINARY RESULTS

Hepatocellular Carcinoma after Treatment of Cirrhotic Hepatitis C Virus Patients with Direct Acting Antiviral Treatment

Clinicoepidemiologic Study of Hepatocellular Carcinoma among HCV Induced Compensated Cirrhotic Patients who Achieved Sustained Virologic Response with Direct Acting Antiviral Dru

Occurrence of hepatocellular carcinoma following direct antiviral agents (DAA) therapy

Frequency of Hepatocellular Carcinoma in Cirrhotic Patients after Chronic Hepatitis C Infection Treatment with Direct-Acting ‎Antivirals

Hepatocellular carcinoma before and after the era of direct-acting antiviral therapy for chronic hepatitis C: Dose the story differ?

Hepatocellular Carcinoma in Hepatitis C Virus Cirrhosis After Treatment with Direct Acting Antiviral Therapy